Health Care & Life Sciences » Biotechnology | Advanced Life Sciences Holdings Inc.

Advanced Life Sciences Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2006
2007
2008
2009
2010
Sales/Revenue
39.80
-
240.80
2,793.20
752.90
Cost of Goods Sold (COGS) incl. D&A
131.10
206.80
218.80
106.90
32.50
Gross Income
91.30
206.80
22.00
2,686.30
720.30
SG&A Expense
22,528.40
32,368.60
22,607.00
10,678.20
6,838.00
Unusual Expense
-
-
-
-
2,510.90
Non Operating Income/Expense
939.10
-
-
146.10
244.50
Interest Expense
511.90
467.00
525.70
1,036.80
946.20
Pretax Income
20,540.60
32,324.40
22,803.90
9,163.20
9,322.00
Consolidated Net Income
20,540.60
32,324.40
22,803.90
9,163.20
9,322.00
Net Income
20,540.60
32,324.40
22,803.90
9,163.20
9,322.00
Net Income After Extraordinaries
20,540.60
32,324.40
22,803.90
9,163.20
9,322.00
Net Income Available to Common
20,715.60
32,499.40
22,978.90
9,338.20
9,497.00
EPS (Basic)
23.40
33.60
17.70
4.80
1.80
Basic Shares Outstanding
884.90
963.70
1,303.30
1,926.00
5,112.40
EPS (Diluted)
23.41
33.72
17.63
4.85
1.86
Diluted Shares Outstanding
884.90
963.70
1,303.30
1,926.00
5,112.40
EBITDA
22,488.60
32,368.60
22,366.20
7,885.00
6,085.20
Non-Operating Interest Income
1,651.90
717.90
306.80
11.60
8.40
Preferred Dividends
175.00
175.00
175.00
175.00
175.00

About Advanced Life Sciences Holdings

View Profile
Address
1440 Davey Road
Woodridge Illinois 60517
United States
Employees -
Website mailto:[email protected]
Updated 07/08/2019
Discovers, develops and distributes novel drugs for infectious diseases .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.